Press Release | Texray today proudly announces that Prof. Dr. Morton J. Kern, one of interventional cardiology’s most respected clinical voices in the USA, has chosen to join our Clinical & Scientific Advisory Board. The appointment reflects a shared standard: Dr. Kern has built his career on holding clinical claims to thorough, evidence-based standards, the same ones that have always guided how we at Texray design and develop our radiation protective products.

BACKGROUND

Dr. Kern served as Chief of Cardiology at the Long Beach Veterans Administration Medical Center and holds a professorship in the Division of Cardiology at the University of California, Irvine, where he has taught since 2006. He came to UC Irvine from St. Louis University, where he was Professor of Medicine and directed the J.G. Mudd Cardiac Catheterization Laboratory. His medical degree, internship, and residency were completed at Mount Sinai Medical Center in New York, followed by a cardiovascular fellowship at Brigham and Women’s Hospital in Boston.

His textbooks are used to train interventional cardiologists internationally, among them Kern’s Cardiac Catheterization Handbook and its companion volume, The Interventional Cardiac Cath Handbook. He has also published the fourth edition of the SCAI Interventional Cardiology Board Review and sits on the editorial board of numerous top ranked US Cardiology Journals.

JOINING TEXRAY

“Radiation exposure in the Cath lab is cumulative and an ever presented challenge for all who work in the cath lab,” says Dr. Morton J. Kern. “The hazards of exposure occur across a career with thousands of procedures, in different settings for the variety of procedures.  The clinical teams as well as the operators carry the brunt of the exposure risks.  For new devices, we would never adopt a device for a patient without scientific evidence, and the same applies to equipment protecting the cath lab staff who deserve that same standard, that is cath lab exposure protection without jeopardizing patient safety. Texray’s work meets both tests, and I am glad to contribute my experience to helping meet that expectation.”

“When validating an X-ray protection device, we know exposure varies across the body and that radiation dose cannot be treated as a single number.  So protection should be measured at multiple anatomical points under real-world procedural conditions,” said Petra Apell, Founder and CEO of Texray. “Showing the wide level of protection is essential evidence, giving clinicians a genuine, informed choice to work without lead aprons. Dr. Kern has spent decades in the cath lab, where occupational radiation exposure is a daily reality. Having his clinical judgment is a true privilege.”

ABOUT TEXRAY

Founded in Sweden and shaped by its high safety standards, Texray AB, with subsidiaries in the USA, is a deep-tech company that has developed the only radiation protection textile in the world. The patented technology platform is currently used in our Personal Protective Equipment, HeadPeace and MindPeace, and in MasterPeace, a recognized Enhanced Radiation Protective Device (ERPD) in the multi-society Standard & Guideline, Expert Consensus Statement on Enhanced Radiation Protection for Interventional Teams.

Our mission is to empower medical professionals to stay healthy through robust, clinically evidence-based solutions that reduce radiation exposure during fluoroscopy-guided interventions, enabling the Freedom of Choice to work without lead aprons and providing Peace of Mind.

🟡 

For more information, please contact Nina Offen Lantz